menu
    • menu

    Company profile for Disc medicine

    NEW Drugs in Dev: 6
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis). Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic disease. Disc Medicine’s therapies are designed to regulate hepcidin expression and treat patients with hematologic dise...
    Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis). Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic disease. Disc Medicine’s therapies are designed to regulate hepcidin expression and treat patients with hematologic diseases. Our core development programs target hepcidin biology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Disc medicineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Technology Square, Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.discmedicine.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Delays Decision On Lilly's Obesity Drug Orforglipron
    FDA Delays Decision On Lilly's Obesity Drug Orforglipron

    17 Jan 2026

    // REUTERS

    https://www.reuters.com/sustainability/boards-policy-regulation/us-fda-delays-two-drug-reviews-new-voucher-program-after-safety-efficacy-2026-01-15/

    REUTERS
    17 Jan 2026
    Share Share
    Disc Medicine Names Lisa Amaya Price, MBA, as Chief HR Officer
    Disc Medicine Names Lisa Amaya Price, MBA, as Chief HR Officer

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217375/0/en/Disc-Medicine-Appoints-Lisa-Amaya-Price-MBA-as-Chief-Human-Resources-Officer.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Disc Medicine To Present At J.P. Morgan Healthcare Conference
    Disc Medicine To Present At J.P. Morgan Healthcare Conference

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214519/0/en/Disc-Medicine-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Disc Med Reveals Promising RALLY-MF Ph2 Results in Myelofibrosis
    Disc Med Reveals Promising RALLY-MF Ph2 Results in Myelofibrosis

    06 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/06/3201048/0/en/Disc-Medicine-Presents-Positive-Initial-Data-from-RALLY-MF-Phase-2-Trial-in-Patients-with-Myelofibrosis-MF-and-Anemia-at-the-67th-American-Society-of-Hematology-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    06 Dec 2025
    Share Share
    Disc Medicine Reports Q3 2025 Financial Results & Business
    Disc Medicine Reports Q3 2025 Financial Results & Business

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182593/0/en/Disc-Medicine-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Disc Medicine Presents Initial Data From RALLY-MF Ph2 Trial
    Disc Medicine Presents Initial Data From RALLY-MF Ph2 Trial

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179386/0/en/Disc-Medicine-Announces-Presentation-of-Initial-Data-from-RALLY-MF-Phase-2-Trial-in-Patients-with-Myelofibrosis-MF-and-Anemia-at-the-67th-American-Society-of-Hematology-ASH-Annual-.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search